TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/23/2022
Back to search
Official data from USPTO
PHARM I-GENE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
49
Latest update
12/23/2022
Trademark type
Combined
Nice classes
5
Filing date
06/01/2007
Registration date
02/24/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/18/2018
Last transaction
10/18/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/17/2007
First use in commerce
07/17/2007
Drawing code
3
Owner type
03
Owner location
Taipei City 11494, TW
Examiner
HETZEL, DANNEAN
Law office
L60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
PharmiGene, Inc.
PharmiGene, Inc.
PharmaGene, Inc.
Representatives
Joe McKinney Muncy MUNCY, GEISSLER, OLDS & LOWE, PC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
biological preparations for medical or veterinary use; chemical preparations for medical or veterinary sanitary use; diagnostic preparations for medical or veterinary use; diagnostic reagents for clinicalmedical laboratory and medicinal use; reagents for medical or veterinary use; contrast media for use with Gene-detection equipment; herbal supplements; pharmaceutical preparations acting on the central nervous system; reagents and media for medical and veterinary diagnostic purposes
Publications
History of USPTO decisions and trademark events.
49 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/23/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/23/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/23/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/18/2018
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/18/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/18/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/18/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
10/09/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/24/2018
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/09/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/09/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/09/2015
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/30/2014
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/30/2014
E815
TEAS SECTION 8 & 15 RECEIVED
12/19/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
02/24/2009
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
01/22/2009
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/13/2009
XAEC
EXAMINER'S AMENDMENT ENTERED
01/13/2009
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/13/2009
GNEA
EXAMINERS AMENDMENT E-MAILED
01/13/2009
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
01/13/2009
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/13/2009
IUAF
USE AMENDMENT FILED
12/29/2008
EISU
TEAS STATEMENT OF USE RECEIVED
12/29/2008
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
11/18/2008
PUBO
PUBLISHED FOR OPPOSITION
08/26/2008
NPUB
NOTICE OF PUBLICATION
08/06/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/18/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/16/2008
XAEC
EXAMINER'S AMENDMENT ENTERED
07/16/2008
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/16/2008
GNEA
EXAMINERS AMENDMENT E-MAILED
07/16/2008
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/16/2008
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/16/2008
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/01/2008
GNFR
FINAL REFUSAL E-MAILED
04/01/2008
CNFR
FINAL REFUSAL WRITTEN
04/01/2008
ACEC
AMENDMENT FROM APPLICANT ENTERED
03/20/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/20/2008
ALIE
ASSIGNED TO LIE
03/20/2008
FAXX
FAX RECEIVED
03/05/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/12/2007
GNRT
NON-FINAL ACTION E-MAILED
09/12/2007
CNRT
NON-FINAL ACTION WRITTEN
09/12/2007
DOCK
ASSIGNED TO EXAMINER
09/11/2007
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
06/07/2007
NWAP
NEW APPLICATION ENTERED
06/06/2007
Continuous trademark protection
Get notified about every new filing that threatens PHARM I-GENE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.